Chimeros' Series B - II Round

Chimeros raised a round of funding on October 14, 2009.

Chimeros is developing a biologics approach to enable delivery of polynucleotide therapeutics such as siRNAs. The company's delivery technology, termed Chimerasomes, is based upon protein building blo…

Articles about Chimeros' Series B - II Round: